🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Alan Melcher

Institute of Cancer Research

ORCID: 0000-0002-2042-3380

Also affiliated with Institute of Cancer Research

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 10 papers. Top paper: “Oncolytic virotherapy as immunotherapy”.

Oncolytic virotherapy as immunotherapy

Science(2021)10.1126/science.abk3436
N/A
0.734DataRank · unranked
132 citations

Kevin Harrington, Richard Vile, Alan Melcher

Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy

Nature Communications(2021)10.1038/s41467-021-22115-1
N/A
0.510DataRank · unranked
29 citations

Jason M. Tonne, Laura Evgin, Christopher B. Driscoll, Jacob P. van Vloten, Victoria A. Jennings +17 more

Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response

Nature Communications(2024)10.1038/s41467-024-49286-x
N/A
0DataRank · unranked
53 citations

Thanich Sangsuwannukul, Jacob P. van Vloten, Laura Evgin, Benjamin Kendall, Jason M. Tonne +13 more

Cancer Immunotherapy Using AIRE Conditioning of the Tumor Epitopeome

Research Square(2024)10.21203/rs.3.rs-5411393/v1
N/A
0DataRank · unranked
1 citations

José S. Pulido, Alex Chen, Benjamin Kendall, Jason M. Tonne, Muriel Metko +12 more

APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy

Nature Communications(2020)10.1038/s41467-020-14568-7
N/A
0DataRank · unranked
78 citations

Matthew Schuelke, Timothy Kottke, Jill Thompson, Phonphimon Wongthida, Jason M. Tonne +15 more

The untapped potential of radiation and immunotherapy for hormone receptor-positive breast cancer

npj Breast Cancer(2025)10.1038/s41523-025-00796-x
N/A
0DataRank · unranked
10 citations

Miki Yoneyama, Erik Wennerberg, Tom Lund, Andrew Tutt, Alan Melcher +3 more

Engagement of the T cell receptor against an oncolytic virus generates a population of hypereffector CAR T cells with potent antitumor activity

Research Square(2025)10.21203/rs.3.rs-7949545/v1
N/A
0DataRank · unranked
0 citations

Olivia Liseth, Elizabeth Appleton, Benjamin Kendall, Jill Thompson, Thanich Sangsuwannukul +8 more

Using oncolytic viruses to exploit endogenous TCR signaling for modulation of CAR T phenotype and function against solid tumors 4322

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.2021
N/A
0DataRank · unranked
0 citations

Elizabeth Appleton, Jill Thompson, Luke Kendall, Laura Evgin, Masahiro Ono +3 more

Oncolytic viruses as anticancer agents: clinical progress and remaining challenges

The Lancet(2025)10.1016/s0140-6736(25)01206-1
N/A
0DataRank · unranked
14 citations

E. Antonio Chiocca, Guy Ungerechts, Alan Melcher, Richard G. Vile, Elizabeth Appleton

APOBEC and Cancer Viroimmunotherapy: Thinking the Unthinkable

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-1888
N/A
0DataRank · unranked
31 citations

Alan Melcher, Hardev Pandha, Kevin J. Harrington, José S. Pulido, Richard G. Vile